Desbutal
Desbutal was a combination drug composed of two active ingredients: methamphetamine and pentobarbital. It was used primarily in the mid-20th century for its stimulant and sedative effects. The drug was prescribed for various conditions, including depression, anxiety, and narcolepsy.
Composition and Mechanism of Action
Desbutal combined the stimulant properties of methamphetamine with the sedative effects of pentobarbital. Methamphetamine is a potent central nervous system (CNS) stimulant that increases the release of neurotransmitters such as dopamine and norepinephrine, leading to increased alertness, concentration, and energy. Pentobarbital, on the other hand, is a barbiturate that acts as a CNS depressant, producing sedative and hypnotic effects by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA).
Medical Uses
Desbutal was prescribed for a variety of conditions:
- Depression: The stimulant component helped alleviate symptoms of depression by increasing energy and mood.
- Anxiety: The sedative component helped reduce anxiety and promote relaxation.
- Narcolepsy: The stimulant component helped manage excessive daytime sleepiness and sudden sleep attacks.
Side Effects and Risks
The combination of a stimulant and a sedative in Desbutal posed significant risks, including:
- Addiction: Both methamphetamine and pentobarbital have high potential for abuse and dependence.
- Cardiovascular issues: The stimulant effects of methamphetamine could lead to increased heart rate and blood pressure.
- Respiratory depression: The sedative effects of pentobarbital could cause respiratory depression, especially in high doses.
Regulation and Discontinuation
Due to the high potential for abuse and the availability of safer alternatives, Desbutal was eventually discontinued. The Controlled Substances Act and other regulatory measures led to stricter controls on the prescription and distribution of both methamphetamine and pentobarbital.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD